It lets you identify your optimal retatrutide dose while minimizing side effects that could derail your research timeline
doi:10.1016/j.biopha.2019.01.041 229
Side effects and compounding complications Semaglutide, approved by the FDA in 2017, is known for causing stomach and bowel side effects, including nausea, vomiting, and constipation, especially when patients initially start the medication
Holst JJ, Knop FK, Vilsboll T, Krarup T, Madsbad S
PLoS ONE 8 , e81587 (2013)
There is a lot of individuality at work here." Rediscovering what's in your fridge A September 2025 survey by International Flavors & Fragrances, Inc., found 85% GLP-1 users have had major changes in food preferences, including developing strong aversions to fatty foods, fried items, sweets, coffee and alcohol